An estimated 11,000 spinal cord injuries occur each year in the United States and more than 200,000 Americans suffer from maladies associated with spinal cord injury. This includes paralysis, bowel and bladder dysfunction, sexual dysfunction, respiratory impairment, temperature regulation problems, and chronic pain. During the last two decades, longstanding beliefs about the inability of the adult central nervous system to heal itself have been eroded by the flood of new information from research in the neurosciences and related fields. However, there are still no cures and the challenge of restoring function in the wake of spinal cord injuries remains extremely complex.
Spinal Cord Injury examines the future directions for research with the goal to accelerate the development of cures for spinal cord injuries. While many of the recommendations are framed within the context of the specific needs articulated by the New York Spinal Cord Injury Research Board, the Institute of Medicine s panel of experts looked very broadly at research priorities relating to future directions for the field in general and make recommendations to strengthen and coordinate the existing infrastructure. Funders at federal and state agencies, academic organizations, pharmaceutical and device companies, and non-profit organizations will all find this book to be an essential resource as they examine their opportunities.
Table of Contents
|2 Progression of Spinal Cord Injury||30-63|
|3 Tools for Assessing Spinal Cord Injury and Repair||64-94|
|4 Current Therapeutic Interventions||95-120|
|5 Progress Toward Neuronal Repair and Regeneration||121-151|
|6 Developing New Therapeutic Interventions: From the Laboratory to the Clinic||152-182|
|7 Research Organization: Creating an Environment to Accelerate Progress||183-204|
|8 State Programs in Spinal Cord Injury||205-242|
|Appendix A Study Process||243-248|
|Appendix B Acronyms||249-251|
|Appendix C Glossary of Major Terms||252-259|
|Appendix D Tools to Assess Spinal Cord Injury Outcomes||260-267|
|Appendix E Clinical Trials of Methylprednisolone||268-274|
|Appendix F Examples of Alternative Therapies||275-277|
|Appendix G Spinal Cord Injury Clinical Trials Published from 1998 to 2003||278-319|
|Appendix H Legislation Sponsoring State Spinal Cord Injury Research||320-322|
|Appendix I Committee and Staff Biographies||323-332|
The National Academies Press (NAP) has partnered with Copyright Clearance Center's Rightslink service to offer you a variety of options for reusing NAP content. Through Rightslink, you may request permission to reprint NAP content in another publication, course pack, secure website, or other media. Rightslink allows you to instantly obtain permission, pay related fees, and print a license directly from the NAP website. The complete terms and conditions of your reuse license can be found in the license agreement that will be made available to you during the online order process. To request permission through Rightslink you are required to create an account by filling out a simple online form. The following list describes license reuses offered by the National Academies Press (NAP) through Rightslink:
Click here to obtain permission for the above reuses. If you have questions or comments concerning the Rightslink service, please contact:
Rightslink Customer Care
Tel (toll free): 877/622-5543
To request permission to distribute a PDF, please contact our Customer Service Department at 800-624-6242 for pricing.
To request permission to translate a book published by the National Academies Press or its imprint, the Joseph Henry Press, please click here to view more information.